短程住院EVAR安全且具成本效益
该系统综述检索Ovid MEDLINE(1996年至2018年4月)和Embase(1974年至2018年4月),评估短程住院路径下EVAR的安全性、可行性与成本效益。5项合适研究中450例(75%)患者于术后当日或次日成功出院,早期出院者再入院率0-5%且30天再入院无差异;早期出院带来显著成本节约,从£13,360(住院4天)降至£9,844(住院1天)。结论认为经选择的患者可安全接受短程住院EVAR,术后6小时监测对低风险患者已足够。
要点
- 5项研究中450例(75%)患者于EVAR术后当日或次日成功出院。
- 早期出院者再入院率0-5%,30天再入院无差异。
- 早期出院成本节约从£13,360(住院4天)至£9,844(住院1天)。
核心结论
- 经选择的患者可安全接受短程住院路径下的EVAR。
- 对低风险患者,术后6小时监测期已足够。
- 将英国EVAR术后住院时间从当前中位数三天缩短至1.5天,可释放4361个床位日并每年节约约£1,800,000。
研究设计与样本
- 系统综述,检索Ovid MEDLINE(1996年至2018年4月)和Embase(1974年至2018年4月),遵循PRISMA指南,采用Newcastle-Ottawa量表评估研究偏倚。
- 文献检索共识别570篇论文,筛选32篇摘要,评估9篇论文的合格性,最终纳入5项合适研究。
主要发现
- 5项合适研究中,450例(75%)患者在EVAR术后当日或次日成功出院。
- 并发症最常发生于术后3小时内,需重症治疗单元收治的主要并发症发生于6小时内。
- 早期出院者再入院率为0-5%,30天再入院无差异。
- 早期出院带来统计学显著的成本节约,从£13,360(住院4天)至£9,844(住院1天)。
关键数值与推荐
- 低风险患者术后6小时监测期已足够。
临床怎么用
- 经选择的患者可采用短程住院路径接受EVAR。
- 低风险患者术后监测6小时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Reducing length of stay (LOS) following surgery offers the potential to improve resource utilisation. Endovascular aneurysm repair (EVAR) is now delivered with a low level of morbidity and as such may be deliverable as a "23 hour stay" intervention. This systematic review aims to assess safety, feasibility and cost effectiveness of a short stay EVAR pathway. METHODS: A database search of Ovid MEDLINE (1996 - April 2018) and Embase (1974 - April 2018) was completed. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used. A Newcastle-Ottawa Scale was applied to assess study bias. RESULTS: In total, 570 papers were identified through the literature search, of which 32 abstracts were screened. This led to nine papers being assessed for eligibility. From five suitable studies, 450 (75%) patients were successfully discharged the same or next day after EVAR. Complications most often occurred within 3 hours of surgery, and major complications requiring intensive treatment unit admission occurred within 6 hours. Readmission rates were 0-5% for those discharged early, with no difference in 30 day readmission. Early discharge led to a statistically significant cost saving of £13,360 (LOS four days) to £9844 (LOS one day). CONCLUSION: Selected patients can safely undergo EVAR using a short stay pathway. A period of monitoring 6 h post-operatively for low risk patients would be sufficient. Reducing length of stay after EVAR in the UK from the current median of three days to 1.5 days would free 4361 bed days and lead to a saving of approximately £1,800,000 annually.
引用
- Shaw SE, Preece R, Stenson KM, et al. Short Stay EVAR is Safe and Cost Effective. Eur J Vasc Endovasc Surg. 2018. PMID: 30442563. doi:10.1016/j.ejvs.2018.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。